Literature DB >> 31152789

Nucleocytoplasmic transport defects in neurodegeneration - Cause or consequence?

Saskia Hutten1, Dorothee Dormann2.   

Abstract

Defects in nucleocytoplasmic transport have been associated with several neurodegenerative disorders and, in particular, the formation of pathological protein aggregates characteristic for the respective disease. However, whether impaired nucleocytoplasmic transport is a consequence of such aggregates or rather contributes to their formation is still mostly unclear. In this review, we summarize recent findings how both soluble and stationary components of the nucleocytoplasmic transport machinery are altered in neurodegenerative diseases, in particular amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer's disease (AD) and Huntington's disease (HD). We discuss the functional significance of the observed defects for nucleocytoplasmic transport of proteins and mRNAs. Moreover, we highlight interesting parallels observed in physiological ageing and the premature ageing syndrome progeria and propose that they that might provide mechanistic insights also for neurodegenerative processes.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Neurodegeneration; Nuclear pore complex; Nuclear transport receptor; Nucleocytoplasmic transport; Nucleoporin; RNA binding protein

Mesh:

Year:  2019        PMID: 31152789     DOI: 10.1016/j.semcdb.2019.05.020

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  26 in total

Review 1.  Brain Cell Type-Specific Nuclear Proteomics Is Imperative to Resolve Neurodegenerative Disease Mechanisms.

Authors:  Ruth S Nelson; Eric B Dammer; Juliet V Santiago; Nicholas T Seyfried; Srikant Rangaraju
Journal:  Front Neurosci       Date:  2022-06-16       Impact factor: 5.152

2.  Cellular Stress Induces Nucleocytoplasmic Transport Deficits Independent of Stress Granules.

Authors:  Joni Vanneste; Thomas Vercruysse; Steven Boeynaems; Philip Van Damme; Dirk Daelemans; Ludo Van Den Bosch
Journal:  Biomedicines       Date:  2022-05-03

3.  The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson's disease SNCA mutations.

Authors:  Vivian Chen; Malik Moncalvo; Dominic Tringali; Lidia Tagliafierro; Ahila Shriskanda; Ekaterina Ilich; Wendy Dong; Boris Kantor; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2020-11-04       Impact factor: 6.150

Review 4.  Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD.

Authors:  Claudia Fallini; Bilal Khalil; Courtney L Smith; Wilfried Rossoll
Journal:  Neurobiol Dis       Date:  2020-03-14       Impact factor: 5.996

5.  Quantitative Nucleocytoplasmic Transport Assays in Cellular Models of Neurodegeneration.

Authors:  Joni Vanneste; Thomas Vercruysse; Philip Van Damme; Ludo Van Den Bosch; Dirk Daelemans
Journal:  Bio Protoc       Date:  2020-06-20

6.  The RNA-binding protein FUS is chaperoned and imported into the nucleus by a network of import receptors.

Authors:  Imke Baade; Saskia Hutten; Erin L Sternburg; Marius Pörschke; Mario Hofweber; Dorothee Dormann; Ralph H Kehlenbach
Journal:  J Biol Chem       Date:  2021-04-12       Impact factor: 5.157

7.  Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway.

Authors:  Yen-Chen Lin; Meenakshi Sundaram Kumar; Nandini Ramesh; Eric N Anderson; Aivi T Nguyen; Boram Kim; Simon Cheung; Justin A McDonough; William C Skarnes; Rodrigo Lopez-Gonzalez; John E Landers; Nicolas L Fawzi; Ian R A Mackenzie; Edward B Lee; Jeffrey A Nickerson; David Grunwald; Udai B Pandey; Daryl A Bosco
Journal:  Nat Neurosci       Date:  2021-05-31       Impact factor: 24.884

8.  G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD.

Authors:  Alyssa N Coyne; Benjamin L Zaepfel; Lindsey Hayes; Boris Fitchman; Yuval Salzberg; En-Ching Luo; Kelly Bowen; Hannah Trost; Stefan Aigner; Frank Rigo; Gene W Yeo; Amnon Harel; Clive N Svendsen; Dhruv Sareen; Jeffrey D Rothstein
Journal:  Neuron       Date:  2020-07-15       Impact factor: 17.173

9.  Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology.

Authors:  Eric N Anderson; Andrés A Morera; Sukhleen Kour; Jonathan D Cherry; Nandini Ramesh; Amanda Gleixner; Jacob C Schwartz; Christopher Ebmeier; William Old; Christopher J Donnelly; Jeffrey P Cheng; Anthony E Kline; Julia Kofler; Thor D Stein; Udai Bhan Pandey
Journal:  Elife       Date:  2021-05-26       Impact factor: 8.140

10.  Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS.

Authors:  Alyssa N Coyne; Victoria Baskerville; Benjamin L Zaepfel; Dennis W Dickson; Frank Rigo; Frank Bennett; C Patrick Lusk; Jeffrey D Rothstein
Journal:  Sci Transl Med       Date:  2021-07-28       Impact factor: 19.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.